Crossed Leg Sign and it's Correlation With Significant Pathology
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01569542 |
Recruitment Status
: Unknown
Verified March 2012 by Uelk, J. Daniel, D.O..
Recruitment status was: Not yet recruiting
First Posted
: April 3, 2012
Last Update Posted
: April 3, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Pathology |
Study Type : | Observational |
Estimated Enrollment : | 400 participants |
Observational Model: | Case Control |
Time Perspective: | Prospective |
Official Title: | Crossed Leg Sign and it's Correlation With Significant Pathology |
Study Start Date : | May 2012 |
Estimated Primary Completion Date : | February 2013 |
Estimated Study Completion Date : | February 2013 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Any patient observed in the Emergency Department with sustained crossed legs.
Exclusion Criteria:
- Any patient not observed to have sustained crossed legs and is not being used as a control.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01569542
Contact: John D Uelk, DO | 314-605-4486 | juelk1@hfhs.org | |
Contact: Michael Ward, DO | 908-930-2405 | mward4@hfhs.org |
United States, Michigan | |
Henry Ford Wyandotte Hospital | Not yet recruiting |
Wyandotte, Michigan, United States, 48192 | |
Contact: John D Uelk, DO 314-605-4486 juelk1@hfhs.org | |
Principal Investigator: John D Uelk, DO |
Principal Investigator: | John D Uelk, DO | Henry Ford Health System |
Responsible Party: | Uelk, J. Daniel, D.O. |
ClinicalTrials.gov Identifier: | NCT01569542 History of Changes |
Other Study ID Numbers: |
John Daniel Uelk Henry Ford Wyandotte Hospital ( Other Identifier: Henry Ford Wyandotte Hospital ) |
First Posted: | April 3, 2012 Key Record Dates |
Last Update Posted: | April 3, 2012 |
Last Verified: | March 2012 |